Key result
Standard diagnostic tools for acute coronary syndromes are often unreliable independently, highlighting the need for more effective strategies like bedside cardiac multibiomarker assays.
Why the study?
Does a bedside cardiac multibiomarker assay improve the rapid and accurate diagnosis of acute coronary syndromes in emergency department patients with chest pain?
Population
Emergency department patients presenting with chest pain
Comparison
Bedside cardiac multibiomarker assay vs Standard diagnostic tools
Design
Review
Authors
Loading...
Cautions against sole reliance on standard ACS diagnostics; leaves open the value of bedside multibiomarker assays pending validation.
Does a bedside cardiac multibiomarker assay improve the rapid and accurate diagnosis of acute coronary syndromes in emergency department patients with chest pain?
The abstract highlights the clinical need for bedside cardiac multibiomarker assays to improve the rapid and accurate diagnosis of acute coronary syndromes in emergency department patients with chest pain.
Dadkhah et al. (2007) conducted a review in Acute Coronary Syndromes. Bedside cardiac multibiomarker assay vs. Standard diagnostic tools (history, physical examination, 12-lead ECG) was evaluated. Standard diagnostic tools for acute coronary syndromes are often unreliable independently, highlighting the need for more effective strategies like bedside cardiac multibiomarker assays.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: